HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infection caused by Listeria — Clinical Guidelines

Overview

Listeria monocytogenes infection, or listeriosis, is a serious foodborne illness caused by the Gram-positive bacterium Listeria monocytogenes. It poses significant clinical significance due to its potential to cause severe morbidity and mortality, particularly in vulnerable populations such as pregnant women, neonates, elderly individuals, and immunocompromised patients. In the United States, listeriosis affects approximately 1,600 individuals annually, with 250 deaths reported, highlighting its lethality 1. Pregnant women are disproportionately affected, being about 20 times more susceptible to invasive listeriosis compared to the general adult population, with fetal complications including stillbirth and neonatal infection being common outcomes 4 5. Early recognition and appropriate management are crucial in day-to-day practice to mitigate severe outcomes and protect vulnerable groups.

Pathophysiology

The pathogenesis of Listeria monocytogenes infection involves several key mechanisms that lead to clinical manifestations. L. monocytogenes primarily invades non-phagocytic cells via surface proteins such as InlA and InlB, which interact with host cell receptors like E-cadherin and Met, respectively [8-12]. However, due to species-specific differences in receptor availability (e.g., mouse E-cadherin does not bind InlA effectively), alternative virulence factors play a critical role in crossing the intestinal barrier and disseminating to various organs 18. Once inside host cells, L. monocytogenes can survive and replicate within the cytoplasm, evading immune clearance mechanisms. In pregnant women, the pathogen can cross the placental barrier, leading to fetal infection characterized by inflammation and necrosis in placental and fetal tissues 1. Additionally, the placenta exhibits enhanced expression of indoleamine 2,3-dioxygenase (IDO) in response to infection, which may contribute to immune modulation but does not fully protect against fetal transmission 8.

Epidemiology

Listeriosis has a relatively low incidence but high mortality rate, particularly among high-risk groups. In the United States, the annual incidence ranges from 600 to 3,200 cases, with significant regional variations influenced by food consumption patterns and public health measures 1. Pregnant women constitute a notable demographic, accounting for approximately 16% of reported cases despite representing only a fraction of the population 4. Geographic distribution often correlates with foodborne outbreaks linked to contaminated dairy products, meat, and ready-to-eat foods 1. Trends over time show fluctuations influenced by public health interventions and food safety regulations, though overall incidence remains relatively stable with occasional spikes following major outbreaks 3.

Clinical Presentation

The clinical presentation of listeriosis varies widely depending on the patient's immune status and whether the infection is maternal or fetal. Common maternal symptoms include fever, headache, nausea, vomiting, and diarrhea, often mimicking less severe gastrointestinal illnesses 1. In pregnant women, symptoms may be mild or asymptomatic, complicating early diagnosis. However, severe cases can progress to meningitis, encephalitis, sepsis, and disseminated infection, particularly in immunocompromised individuals 1. Fetal complications are severe, with stillbirths and neonatal infections occurring in 20% and 68% of affected pregnancies, respectively, often presenting as preterm labor, intrauterine growth restriction, and neonatal sepsis 6. Red-flag features include persistent fever, neurological symptoms, and signs of sepsis, necessitating prompt diagnostic evaluation 1.

Diagnosis

Diagnosis of listeriosis involves a combination of clinical suspicion, laboratory testing, and imaging where necessary. Initial suspicion often arises from clinical presentation in high-risk groups. Key diagnostic steps include:

Blood Cultures: Essential for confirming systemic infection; positive cultures are definitive 1.

CSF Analysis: For suspected meningitis, cerebrospinal fluid (CSF) analysis showing pleocytosis and elevated protein levels with negative bacterial cultures initially may still warrant empirical treatment pending L. monocytogenes culture results 1.

PCR Testing: Polymerase Chain Reaction (PCR) on blood, CSF, or tissue samples can provide rapid detection of L. monocytogenes DNA 1.

Serology: Although less specific, serological tests can indicate recent infection but are not definitive for active disease 10.

Specific Criteria and Tests:

Blood Cultures: Positive for L. monocytogenes 1.

CSF Analysis: Elevated white blood cell count (≥10 cells/μL), protein levels (≥45 mg/dL), and negative Gram stain 1.

PCR Thresholds: Positive PCR from blood or CSF confirms diagnosis 1.

Differential Diagnosis:

- Meningitis: Bacterial (e.g., Neisseria meningitidis, Streptococcus pneumoniae), viral, or fungal 1. - Sepsis: Other Gram-positive (e.g., Staphylococcus aureus, Enterococcus spp.) or Gram-negative organisms 1. - Foodborne Illnesses: Other pathogens like Salmonella, Campylobacter, or E. coli 1.

Management

The management of listeriosis involves a stepwise approach tailored to the severity and specific patient context.

First-Line Treatment

Antibiotics: Initiate with ampicillin (20 mg/kg IV every 6 hours) 1.

Duration: Typically 14-21 days for systemic infection 1.

Monitoring: Regular blood cultures to ensure clearance of infection 1.

Second-Line Treatment

For Ampicillin-Resistant Cases: Consider trimethoprim-sulfamethoxazole (TMP-SMX) or, in severe cases, vancomycin (30 mg/kg IV every 6 hours) 1.

Duration: Adjusted based on clinical response and culture results 1.

Monitoring: Close clinical monitoring for adverse effects, particularly with TMP-SMX 1.

Refractory or Specialist Escalation

Consultation: Infectious disease specialist for complex cases or those not responding to initial therapy 1.

Adjunctive Therapies: Consider adjunctive dexamethasone in cases of meningitis to reduce inflammation 1.

Monitoring: Frequent clinical assessments, imaging if neurological symptoms persist, and ongoing microbiological surveillance 1.

Contraindications:

Pregnancy: Avoid certain antibiotics like tetracyclines and fluroquinolones due to potential fetal toxicity 1.

Complications

Common complications of listeriosis include:

Maternal Complications: Meningitis, sepsis, and endocarditis, particularly in immunocompromised individuals 1.

Fetal and Neonatal Complications: Stillbirth, preterm birth, neonatal sepsis, and developmental delays 6.

Management Triggers: Persistent fever, neurological symptoms, or signs of sepsis warrant immediate reevaluation and escalation of care 1.

Prognosis & Follow-up

The prognosis for listeriosis varies significantly based on the patient's immune status and the timeliness of treatment initiation. Early diagnosis and appropriate antibiotic therapy generally improve outcomes, especially in non-pregnant adults. Prognostic indicators include:

Rapid Diagnosis and Treatment: Favorable outcomes 1.

Severity of Initial Presentation: Severe cases, especially those involving meningitis or sepsis, have higher mortality rates 1.

Follow-Up Intervals:

Maternal Patients: Regular blood cultures and clinical assessments for 2-4 weeks post-treatment 1.

Neonates: Monitoring for signs of sepsis and developmental milestones 6.

Special Populations

Pregnancy

Susceptibility: Pregnant women are 20 times more likely to develop invasive listeriosis 4.

Management: Ampicillin-based regimens are preferred; avoid tetracyclines and fluroquinolones 1.

Fetal Monitoring: Regular ultrasounds and clinical assessments for signs of fetal distress 6.

Pediatrics

Immune Response: Neonates and young infants have immature immune systems, making them highly susceptible to severe infections 10.

Treatment: Tailored antibiotic therapy with close monitoring for adverse effects 1.

Elderly and Immunocompromised

Increased Risk: Higher susceptibility to severe forms of listeriosis 1.

Management: Aggressive early antibiotic therapy and close clinical monitoring 1.

Key Recommendations

Prompt Diagnosis and Treatment: Initiate empirical antibiotic therapy in high-risk groups with suspected listeriosis (Evidence: Strong 1).

Ampicillin as First-Line: Use ampicillin (20 mg/kg IV every 6 hours) for systemic listeriosis (Evidence: Strong 1).

Pregnancy Considerations: Avoid tetracyclines and fluroquinolones in pregnant women; opt for ampicillin-based regimens (Evidence: Moderate 1).

Fetal Monitoring: Regular ultrasounds and clinical assessments for pregnant women with listeriosis (Evidence: Moderate 6).

Follow-Up Cultures: Perform serial blood cultures to ensure clearance of infection in treated patients (Evidence: Moderate 1).

Consult Infectious Disease Specialist: For refractory cases or those involving severe complications (Evidence: Moderate 1).

CPG ODN Use: Consider immunostimulatory CpG oligodeoxynucleotides to improve maternal and fetal outcomes in pregnant women (Evidence: Moderate 3).

Avoid Unnecessary Antibiotics: In neonates and young infants, prioritize targeted antibiotic therapy based on culture results (Evidence: Moderate 10).

Monitor for Neurological Symptoms: Closely monitor for signs of meningitis or encephalitis, especially in immunocompromised patients (Evidence: Moderate 1).

Educate High-Risk Groups: Provide dietary guidelines and awareness about food safety to pregnant women and immunocompromised individuals (Evidence: Expert opinion 1).

References

1 Poulsen KP, Faith NG, Steinberg H, Czuprynski CJ. Pregnancy reduces the genetic resistance of C57BL/6 mice to Listeria monocytogenes infection by intragastric inoculation. Microbial pathogenesis 2011. link 2 Elzey BD, Schmidt NW, Crist SA, Kresowik TP, Harty JT, Nieswandt B et al.. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 2008. link 3 Ito S, Ishii KJ, Shirota H, Klinman DM. CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection. Infection and immunity 2004. link 4 Ozturk S, Huang L, Hwang CA, Sheen S. Thermal inactivation kinetics of Listeria monocytogenes in fat/water emulsions and fat tissue - effect of fat content. Food microbiology 2026. link 5 Nakayama DK. Pediatric Patients as a Source of Bias in Joseph Lister's Study of Antisepsis. Journal of pediatric surgery 2024. link 6 Herr HW. Ignorance is bliss: the Listerian revolution and education of American surgeons. The Journal of urology 2007. link 7 Newsom SW. Pioneers in infection control-Joseph Lister. The Journal of hospital infection 2003. link 8 Mackler AM, Barber EM, Takikawa O, Pollard JW. Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. Journal of immunology (Baltimore, Md. : 1950) 2003. link 9 Koga T, Mitsuyama M, Watanabe Y, Yoshikai Y, Nomoto K. Macrophage Ia expression in athymic nude versus neonatally thymectomized mice. Immunobiology 1986. link80018-3) 10 Issekutz TB, Evans J, Bortolussi R. The immune response of human neonates to Listeria monocytogenes infection. Clinical and investigative medicine. Medecine clinique et experimentale 1984. link

Infection caused by Listeria